Navigating the Pfizer Learning Academy: Vaccine Management and Updates
The Pfizer Learning Academy offers resources crucial for healthcare professionals involved in vaccine handling, storage, and administration. These resources, particularly those concerning the Pfizer-BioNTech COVID-19 vaccine, provide comprehensive training on various aspects of vaccine management, from understanding different formulations to establishing ultra-cold chain systems. This article aims to provide an overview of the training modules offered and relevant updates concerning vaccine availability and ordering procedures.
Comprehensive Training Modules
The training slide set from the Pfizer Learning Academy is meticulously organized into 16 modules, each addressing a specific aspect of vaccine management. These modules are designed to cater to the diverse training needs and profiles of participants, ensuring effective knowledge transfer and skill development.
Module 1: Product Overview: Pfizer-BioNTech COVID-19 Vaccine/COMIRNATY®
This module provides a detailed introduction to the Pfizer-BioNTech COVID-19 vaccine, also known as COMIRNATY®. It covers the vaccine's composition, mechanism of action, and key characteristics.
Module 2: Packaging and Labeling Information
Understanding the packaging and labeling of vaccines is crucial for proper handling and identification. This module offers comprehensive information on the packaging components, labeling requirements, and key identifiers for the Pfizer-BioNTech COVID-19 vaccine.
Module 3: Monitoring Vaccine Expiration Date and Shelf Life
Ensuring that vaccines are administered before their expiration date is paramount for maintaining efficacy and patient safety. This module provides guidance on how to effectively monitor vaccine expiration dates and manage shelf life to minimize wastage.
Read also: Understanding PLCs
Module 4: WHO Guidance on Off-Label Use of Vaccines
This module delves into the World Health Organization's (WHO) guidance on the off-label use of vaccines. It provides insights into the ethical and practical considerations surrounding the use of vaccines outside of their approved indications.
Module 5: Vaccination Schedule Based on WHO SAGE Recommendations
The Strategic Advisory Group of Experts on Immunization (SAGE) provides recommendations on vaccination schedules. This module outlines the recommended vaccination schedule for the Pfizer-BioNTech COVID-19 vaccine based on WHO SAGE guidelines.
Module 6: Operational Considerations on Vaccine Management and Administration
Effective vaccine management and administration require careful consideration of various operational factors. This module addresses key operational considerations, such as staff training, facility requirements, and logistical planning.
Module 7: Shipping and Vaccine Arrival Procedures
Proper shipping and receiving procedures are essential for maintaining vaccine integrity. This module provides detailed guidance on shipping protocols, receiving procedures, and documentation requirements.
Module 8: Recommended Vaccine Deployment Strategies
Efficient vaccine deployment is critical for maximizing coverage and minimizing wastage. This module explores various vaccine deployment strategies, taking into account factors such as target populations, geographical considerations, and resource availability.
Read also: Learning Resources Near You
Module 9: Orientation on Thermal Shipping Containers
Thermal shipping containers play a vital role in maintaining the cold chain during vaccine transport. This module provides an orientation on the different types of thermal shipping containers used for vaccine transport, their features, and proper handling procedures.
Module 10: Orientation on Temperature Data Loggers
Temperature data loggers are essential tools for monitoring vaccine temperature during storage and transport. This module offers an orientation on temperature data loggers, their functionality, and how to interpret the data they provide.
Module 11: Equipment Options for Storing Vaccines at Ultra-Low Temperature
Certain vaccines, such as the Pfizer-BioNTech COVID-19 vaccine, require ultra-low temperature (ULT) storage. This module explores the different equipment options available for ULT storage, including their advantages and disadvantages.
Module 12: Orientation on Ultra-Low Temperature (ULT) Freezers and Selection Criteria
ULT freezers are specialized freezers designed to maintain extremely low temperatures. This module provides an in-depth orientation on ULT freezers, their features, and the key criteria to consider when selecting a ULT freezer for vaccine storage.
Module 13: Ultra-Cold Chain (UCC) System Readiness
Establishing a robust ultra-cold chain (UCC) system is crucial for ensuring the integrity of vaccines that require ULT storage. This module outlines the key components of a UCC system and the steps necessary to ensure system readiness.
Read also: Learning Civil Procedure
Module 14: Options for Transporting ULT Frozen Vaccines to Subnational Stores
Transporting ULT frozen vaccines to subnational stores presents unique challenges. This module explores the various options available for transporting ULT frozen vaccines, taking into account factors such as distance, infrastructure, and resource constraints.
Module 15: Options for Transporting and Storing Vaccines at Lower-Level Stores and Service Points
Maintaining the cold chain at lower-level stores and service points is essential for ensuring vaccine efficacy. This module provides guidance on the options available for transporting and storing vaccines at these locations, considering factors such as temperature control, storage capacity, and monitoring requirements.
Module 16: Managing Vaccine Storage and Transport at Service Points
The final module focuses on the practical aspects of managing vaccine storage and transport at service points. It covers topics such as temperature monitoring, inventory management, and emergency procedures.
Important Vaccine Updates and Information
Beyond the comprehensive training modules, the Pfizer Learning Academy and related resources provide crucial updates regarding vaccine availability, ordering procedures, and product discontinuations. Staying informed about these updates is essential for healthcare providers to effectively manage their vaccine supply and ensure optimal patient care.
Vaccines for Children (VFC) Program
The Vaccines for Children (VFC) Program plays a vital role in providing vaccines to eligible children. It's important to note that the VFC program is not experiencing delays in order review. However, if an order is in "Corrections Needed" status, providers should promptly review and resubmit with the necessary corrections to avoid delays in fulfillment. Typically, providers can expect to receive their vaccines within 14 days after receiving the order processed notification.
Specific Vaccine Availability and Discontinuations
Several important updates concern the availability and discontinuation of specific vaccines:
- Hiberix: The presentation of Hiberix (NDC 58160-0818-11) is no longer available. A new presentation of Hiberix (NDC 58160-0726-15) is available for order.
- COVID-19 Vaccines: As of the specified date, providers should remove any remaining doses of the specified COVID-19 vaccine products from their inventory. When completing a return form, these doses should be reported as spoiled and returned to McKesson. The specified COVID-19 vaccine products will remain on the order form only to report doses administered since the last order prior to deauthorization.
- Prevnar 13: As of September 1, 2023, Prevnar 13 is no longer available.
- MenQuadfi: As of August 9, 2024, the MenQuadfi Single Dose Vials - 5 per box (NDC 49281-0590-05) presentation has been discontinued.
- Menveo: The new Menveo one-vial presentation is available for ordering. The existing Menveo two-vial presentation will be available in limited amounts and should be targeted for use in children aged 2 months through 2 years of age at high risk for Meningococcal disease.
- Menactra: As of June 2, 2022, Menactra has been discontinued.
- ROTARIX: As of March 6, 2023, ROTARIX (NDC 58160-0854-52, a vial and oral dosing applicator) is discontinued.
- FluMist®: FluMist® is no longer available for the season.
tags: #pfizer #learning #academy #courses
